HIV prevention drug hailed as breakthrough, but who gets access?
|
Lenacapavir, a twice-a-year injection could transform HIV
prevention, but it will not be available to all. |
NICE rejects long-acting HIV prevention treatment for NHS use
Lenacapavir, a twice-yearly injection to reduce the risk of HIV infection, should not be routinely available as preventative treatment. View article...